Janae O Hughes

Janae O. Hughes serves as a Contract Specialist within the FDA Office of Acquisition and Grant Services, where she plays a pivotal role in executing procurement strategies that advance the agency’s mission to safeguard public health through scientific integrity and regulatory excellence. She manages complex acquisitions for high-precision analytical instrumentation, laboratory infrastructure, and specialized scientific services critical to FDA’s regulatory science functions. Her portfolio emphasizes technical procurement under FAR Part 15, including negotiated contracts for research support, equipment maintenance, and clinical consulting services, ensuring alignment with federal standards for quality, safety, and performance. Janae maintains consistent working relationships with key contractors such as Tranquil Clinical and Research Consulting Services LLC, Toxicologic Pathology Associates Inc., and Progenics Pharmaceuticals Inc., reflecting a focus on niche scientific and clinical service providers. Her contracting patterns favor long-term, performance-based partnerships with vendors possessing deep domain expertise in toxicology, laboratory operations, and pharmaceutical research support. These relationships are characterized by collaborative engagement, rigorous technical evaluation, and compliance with Good Laboratory Practices (GLP) and other regulatory frameworks essential to FDA’s mission. A strong advocate for small business participation, Janae consistently prioritizes Total Small Business Set-Asides, with nearly 76% of her awards designated for small businesses under FAR 19.5. Her socioeconomic contracting strategy reflects a deliberate emphasis on expanding market access for small businesses with specialized scientific capabilities, reinforcing the FDA’s commitment to inclusive procurement and innovation through diversity. Her primary NAICS focus lies in Analytical Laboratory Instrument Manufacturing (334516) and Laboratory and Diagnostic Services (811219), underscoring her technical expertise in procuring advanced instrumentation, calibration services, and specialized analytical support. She also engages in research services under NAICS 541720, demonstrating a nuanced understanding of the intersection between regulatory science, data integrity, and laboratory operations critical to FDA’s oversight of medical products.